SunTrust Robinson Humphrey Initiates Coverage On Biogen with Buy Rating, Announces $337 Price Target

SunTrust Robinson Humphrey initiates coverage on Biogen (NASDAQ:BIIB) with a Buy rating and a $337 price target.

Benzinga · 11/12/2019 11:12

SunTrust Robinson Humphrey initiates coverage on Biogen (NASDAQ:BIIB) with a Buy rating and a $337 price target.